Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review
Matteo RuggeriFacoltà di Economia, Università Cattolica del Sacro Cuore – sede di Roma, Rome, ItalyAbstract: Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide. HCC is a potential target for cancer surveillance (or screening) as it occurs in wel...
Saved in:
Main Author: | Ruggeri M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of screening for hepatocellular carcinoma: putting the cart before the horse
by: Braillon A
Published: (2012) -
Screening for hepatocellular carcinoma
by: Jarosław Koza, et al.
Published: (2017) -
Screening for hepatocellular carcinoma
by: Jarosław Koza, et al.
Published: (2017) -
Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis
by: Yuemin Nan, et al.
Published: (2024) -
Screening for hepatocellular carcinoma in chronic liver disease: a systematic review and meta-analysis of randomized controlled trials comparing screening methodologies
by: James O'Connell, et al.
Published: (2020)